
The FDA’s new CBER Safety Council separates post-market biologics safety review from approvals, raising oversight for cell and gene therapy developers.
Keynote speakers for ISPE’s 2017 Annual Meeting & Expo include representatives from AstraZeneca and GSK.
On Sep. 21, 2017, the International Society for Pharmaceutical Engineering (ISPE) announced the keynote speakers for its 2017
The ISPE keynote speakers include:
Source:





